Prion Cycle Regulation In Vivo
Prion Cycle Regulation In Vivo
批准号:
7570110
负责人:
TRICIA R. SERIO
金额:
$28.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-01 至 2011-01-31
关键词:
AcetyltransferaseAdoptedBehaviorBiochemicalBiogenesisBiologicalBiological AssayBiological ModelsBiological PhenomenaBiological ProcessCellsChemicalsCollectionComplexCytoplasmDevelopmentDisease ProgressionEukaryotaEventFoundationsGleanGoalsIn VitroIndividualInvestigationKnowledgeLabelLinkMammalsMethodsMolecularMolecular ChaperonesMolecular ConformationNucleic AcidsPhenotypePhysiologicalPrion DiseasesPrionsProcessProtein Structure InitiativeProteinsReadingRegulationRoleSaccharomyces cerevisiae ProteinsStimulusSystemTerminator CodonTrans-ActivatorsTranslationsVariantWorkbasecell growth regulationconformerflexibilityin vivoinsightnon-prionnovelphysical stateprion hypothesisprion-basedprotein functionprotein structuresup35traittransmission process
中文摘要
最近的进展表明,蛋白质物理状态的自我复制既指导着蛋白质的发育,也指导着蛋白质物理状态的发展
传染性海绵状脑病的流行及部分表型性状的遗传
低等真核生物。这一新的生物过程,被称为普瑞恩假说,预测了一个独特的群体
具有采用多种构象状态的能力,具有不同的生理结果
在活体内。因为一重一功能蛋白质不能发挥历史上与
核酸,如传染性和遗传性,了解Pron蛋白质的结构
被限制为允许相关表型的忠实繁殖,但保持足够的灵活性
允许偶尔的状态转换对于理解蛋白质的生理后果至关重要-
只是假设。
低等真核生物的蛋白循环为研究蛋白提供了易于实验处理的模型系统
体内循环调节。例如,酿酒酵母的Sup35蛋白是翻译的一个组成部分
终末复合体,其功能可逆地由蛋白循环调节。在非Prion状态下,Sup35
有助于有效终止(\pst)表型,但在Prion形式中,Sup35‘S的活性受到损害
导致停止密码子通读([PSI+]表型)。而[PSI+]和[PST]表型主要是
稳定,它们自发转换(~1 cell/百万),并可通过以下方式诱导定量转换
化学和分子刺激。
利用这个系统,我们将开始阐明近乎忠诚的人背后的分子机制
通过关注两个贡献因素:不同形式的相互作用,在体内传播Pron形式
当存在于同一细胞中时,反式调节蛋白有效地进行了蛋白的转化。为此,我们将
1)确定体内PrP变异优势的分子基础;2)阐明其分子机制
已知的Sup35/[PS/+]Prion循环调节因子的繁殖和表型转换,
3)筛选和鉴定新的普里恩调节子。总之,这些调查将建立一个
从蛋白质生物发生的角度理解纯蛋白质表型繁殖的框架。一个
以往工作的坚实基础表明,从较低的蛋白质研究中收集到的知识
真核生物清楚而直接地适用于我们对普恩病毒机制及其
哺乳动物的生理后果。
英文摘要
Recent advances suggest that self-replication of protein physical states directs both the development and
spread of the Transmissible Spongiform Encephalopathies and the inheritance of some phenotypic traits in
lower eukaryotes. This novel biological process, known as the prion hypothesis, predicts that a uniquegroup
of proteins has the capacity to adopt multiple conformational states with distinct physiological consequences
in vivo. Since one-fold-one-function proteins are unableto act in roles that have historically been linked to
nucleic acids such as infectivity and inheritance, understandinghow a prion protein's structure can be
constrained to allow the faithful propagation of associated phenotypes but remain sufficiently flexible to
allow occasional transitions in state is crucial to understanding the physiological consequences of the protein-
only hypothesis.
The prion cycles of lower eukaryotesprovide experimentally tractable model systems for studyingprion
cycle regulation in vivo. For example, the Sup35 protein of S. cerevisiae is a component of the translation
termination complex whose function is reversibly modulatedby a prion cycle. In the non-prion state, Sup35
facilitates efficient termination (\pst] phenotype), but in the prion form, Sup35's activity is compromised
leading to stop codon read-through ([PSI+] phenotype). While the [PSI+] and [pst] phenotypes are largely
stable, they spontaneous interconvert (~1 cell/million) and can be induced to quantitatively switch by
chemical and molecular stimuli.
Using this system, we will begin to elucidate the molecular mechanism underlyingthe near-faithful
propagation of prion forms in vivo by focusing on two contributingfactors: the interplay of distinct forms
when present in the same cell and the trans regulators of efficient prion conversion. Toward this end, we will
1) determine the molecular basis of prion variant dominance in vivo,2) elucidate the molecular mechanisms
by which knownregulators of the Sup35/[PS/+] prion cycle modulatepropagation and phenotypic transitions,
and 3) screen for and characterize novel prion regulators. Together, these lines of investigation will build a
framework for understandingprotein-only phenotypic propagation in terms of prion protein biogenesis. A
strong foundation of previous work indicates that the knowledge gleaned from prion studies in lower
eukaryotes is clearly and directly applicable to our understandingof prion mechanisms and their
physiological consequences in mammals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular Mechanisms and Consequences of Protein Misfolding and Resolution
-
批准号:10470161
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2016
-
负责人:TRICIA R. SERIO
-
依托单位:
Cellular Mechanisms and Consequences of Protein Misfolding and Resolution
-
批准号:10206543
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2016
-
负责人:TRICIA R. SERIO
-
依托单位:
Cellular Mechanisms and Consequences of Protein Misfolding and Resolution
-
批准号:10697323
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2016
-
负责人:TRICIA R. SERIO
-
依托单位:
Cellular Mechanisms and Consequences of Protein Misfolding and Resolution
-
批准号:9069469
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2016
-
负责人:TRICIA R. SERIO
-
依托单位:
FASEB SRC on Molecular Mechanism and Physiological Consequences of Protein Aggreg
-
批准号:8597867
-
项目类别:
-
资助金额:$4.18万
-
财政年份:2013
-
负责人:TRICIA R. SERIO
-
依托单位:
The Role of Competitive Forces in Prion Propagation and Appearance
-
批准号:8728281
-
项目类别:
-
资助金额:$27.67万
-
财政年份:2012
-
负责人:TRICIA R. SERIO
-
依托单位:
The Role of Competitive Forces in Prion Propagation and Appearance
-
批准号:8917973
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2012
-
负责人:TRICIA R. SERIO
-
依托单位:
The Role of Competitive Forces in Prion Propagation and Appearance
-
批准号:8258008
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2012
-
负责人:TRICIA R. SERIO
-
依托单位:
The Role of Competitive Forces in Prion Propagation and Appearance
-
批准号:8534796
-
项目类别:
-
资助金额:$27.07万
-
财政年份:2012
-
负责人:TRICIA R. SERIO
-
依托单位:
Prion Cycle Regulation In Vivo
-
批准号:8206123
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2006
-
负责人:TRICIA R. SERIO
-
依托单位:
Prion Cycle Regulation In Vivo
-
批准号:8509900
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2006
-
负责人:TRICIA R. SERIO
-
依托单位:
Prion Cycle Regulation In Vivo
-
批准号:8663919
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2006
-
负责人:TRICIA R. SERIO
-
依托单位:
Prion Cycle Regulation In Vivo
-
批准号:8326047
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2006
-
负责人:TRICIA R. SERIO
-
依托单位:
Prion Cycle Regulation In Vivo
-
批准号:7345492
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2006
-
负责人:TRICIA R. SERIO
-
依托单位:
Prion Cycle Regulation In Vivo
-
批准号:7031895
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2006
-
负责人:TRICIA R. SERIO
-
依托单位:
Prion Cycle Regulation In Vivo
-
批准号:8467721
-
项目类别:
-
资助金额:$29.61万
-
财政年份:2006
-
负责人:TRICIA R. SERIO
-
依托单位:
Prion Cycle Regulation In Vivo
-
批准号:7162087
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2006
-
负责人:TRICIA R. SERIO
-
依托单位:
Modulation of Translation Termination Fidelity
-
批准号:6652031
-
项目类别:
-
资助金额:$15.77万
-
财政年份:2001
-
负责人:TRICIA R. SERIO
-
依托单位:
Modulation of Translation Termination Fidelity
-
批准号:6492681
-
项目类别:
-
资助金额:$9.74万
-
财政年份:2001
-
负责人:TRICIA R. SERIO
-
依托单位:
Modulation of Translation Termination Fidelity
-
批准号:6797266
-
项目类别:
-
资助金额:$15.77万
-
财政年份:2001
-
负责人:TRICIA R. SERIO
-
依托单位:
海外基金